Richard Francis
Directeur Général chez
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Fortune : 41 M $ au 31/05/2026
Profil
Richard Francis is President, Chief Executive Officer & Director at Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA, Inc. since 2023.
Mr. Francis is Director at Mettler-Toledo (Schweiz) GmbH since 2016 and Director at Purespring Therapeutics Ltd. since 2021.
Former roles include Chief Executive Officer & Division Head at Sandoz International GmbH from 2014 to 2019, Chief Executive Officer at Forcefield Therapeutics Ltd., Independent Director at Mettler-Toledo International, Inc. from 2016 to 2025, and Senior Vice President at Biogen, Inc. from 2006 to 2014.
Education includes an undergraduate degree from Manchester Metropolitan University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 05/06/2026 | 1 177 529 ( 0,1% ) | 41 M $ | 31/05/2026 |
Dernières actualités sur Richard Francis
Postes actifs de Richard Francis
| Sociétés | Poste | Début |
|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Directeur Général | 01/01/2023 |
Purespring Therapeutics Ltd.
 Purespring Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics for the treatment of kidney diseases | Directeur/Membre du Conseil | 01/01/2023 |
Mettler-Toledo (Schweiz) GmbH
 Mettler-Toledo (Schweiz) GmbH Industrial MachineryProducer Manufacturing Makes weighing equipment | Directeur/Membre du Conseil | 01/05/2016 |
Teva Pharmaceuticals USA, Inc.
 Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Manufacture and marketing generic pharmaceuticals | Directeur Général | 01/01/2023 |
Anciens postes connus de Richard Francis
| Sociétés | Poste | Fin |
|---|---|---|
| METTLER-TOLEDO INTERNATIONAL, INC. | Directeur/Membre du Conseil | 01/05/2025 |
Sandoz International GmbH
 Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Develops and manufactures generic pharmaceuticals | Directeur Général | 31/03/2019 |
| BIOGEN INC. | Corporate Officer/Principal | 01/01/2014 |
Forcefield Therapeutics Ltd.
 Forcefield Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics to retain heart function via protection of cardiomyocytes | Directeur Général | - |
Formation de Richard Francis
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
69
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Teva Pharmaceutical Industries Ltd.
 Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Mettler-Toledo International, Inc.
 Mettler-Toledo International, Inc. Medical SpecialtiesHealth Technology Manufactures and supplies precision instruments | Health Technology |
Sandoz International GmbH
Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Develops and manufactures generic pharmaceuticals | Health Technology |
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Manufacture and marketing generic pharmaceuticals | Health Technology |
Manchester Metropolitan University
 Manchester Metropolitan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mettler-Toledo (Schweiz) GmbH
Mettler-Toledo (Schweiz) GmbH Industrial MachineryProducer Manufacturing Makes weighing equipment | Producer Manufacturing |
Purespring Therapeutics Ltd.
Purespring Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics for the treatment of kidney diseases | Health Technology |
Forcefield Therapeutics Ltd.
Forcefield Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics to retain heart function via protection of cardiomyocytes | Health Technology |
